Gates recruits Novartis development chief, paper says

Word in the Swiss media is that the Gates Foundation is trying to woo away Novartis' ($NVS) Trevor Mundel, aiming to install him as executive director of global health. Mundel has headed up Novartis' global development efforts since 2008. Report

Suggested Articles

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S. 

The agency has granted Tecentriq a priority review in previously untreated NSCLC, setting up the Roche drug for an approval decision by June 19.

Warren Buffett's Berkshire Hathaway has built a $192 million stake in Biogen, a risky investment considering aducanumab's uncertain future.